ADORA3 and rheumatoid arthritis: Similarly, the whole blood mRNA levels of adenosine A3 receptor (ADORA3) in RA patients were correlated with a non-response to MTX therapy (AUC = 0.7, p = 0.006), and the baseline expression levels of ADORA3 mRNA might be a predictive biomarker of MTX response (87).